GCC Nursing Guide — Paediatric Asthma

ℹ️

GCC Context: Asthma prevalence in children across the UAE and Saudi Arabia reaches 20–30%, among the highest globally. Desert dust storms (shamal), indoor allergens in high-density housing, and shisha smoke exposure are key regional drivers.

🔍

Diagnosis Challenges Under 5 Years

Asthma diagnosis in children under 5 is predominantly clinical — spirometry is unreliable in this age group. Pattern recognition of symptoms is essential.

Key Symptoms to Assess

Episodic wheeze (expiratory, musical)
Recurrent dry cough — especially nocturnal or with exercise
Breathlessness and reduced exercise tolerance
Chest tightness (older children can describe this)

⚠️

Symptoms variable in frequency, often triggered by URTI. Response to bronchodilators (salbutamol trial) supports but does not confirm diagnosis.

📋

Asthma Predictive Index (API)

The API identifies children under 3 with recurrent wheeze likely to develop persistent asthma.

Major Criteria (1 needed)

Parental history of asthma (physician-diagnosed)
Physician-diagnosed atopic dermatitis (eczema)
Sensitisation to ≥1 aeroallergen

Minor Criteria (2 needed)

Allergic rhinitis diagnosed by physician
Wheezing unrelated to colds
Peripheral blood eosinophilia ≥4%

✅

Positive API (1 major + 2 minor, or ≥3 episodes/year): 77% chance of active asthma at school age. Supports early treatment.

⚖️

Differential Diagnosis — Age-Related Wheeze

Condition	Peak Age	Key Features	Distinguishing Points
Bronchiolitis	<1 year (peak 2–6 months)	Wheeze, crackles, tachypnoea, subcostal recession, feeding difficulty	RSV in winter; no response to salbutamol; first episode only
Viral-Induced Wheeze	1–5 years	Wheeze only with URTI; no symptoms between episodes	No atopy, no personal/family history; resolves age 5–6
Asthma	Any age (often >3 years)	Episodic wheeze + cough + breathlessness; nocturnal symptoms; exercise-triggered	Atopy present; responds to bronchodilators; symptom-free intervals
Other (GERD, foreign body, CF, ring vascular)	Variable	Persistent stridor, failure to thrive, focal signs	No seasonal pattern; poor response to asthma Rx; investigate further

🌡️

Triggers — Children vs GCC Context

Common Triggers in Children

GCC-Specific Triggers

📊

Severity Classification (BTS/SIGN)

IntermittentSymptoms ≤2/week, no nocturnal symptoms, PEFR normal

Mild Persistent>2/week, nocturnal >2/month, PEFR ≥80%

Moderate PersistentDaily symptoms, nocturnal >1/week, PEFR 60–80%

Severe PersistentContinuous symptoms, frequent nocturnal, PEFR <60%

Objective Monitoring Tools

Peak flow meters: Reliable in children ≥5 years; compare to predicted for height/age
FeNO (fractional exhaled NO): Elevated in eosinophilic airway inflammation; supports diagnosis and monitors ICS adherence
Spirometry: Useful ≥5–6 years — look for obstructive pattern with reversibility

💨

Age-Appropriate Inhaler Devices

Age Group	Recommended Device	Interface	Notes
<2 years	pMDI + spacer	Face mask (tightly fitting)	Parent/carer holds device; tidal breathing technique; 5 breaths per actuation
2–4 years	pMDI + spacer	Mouthpiece (when good seal achieved)	Transition from mask when child can maintain lip seal; still tidal breathing
5+ years	pMDI + spacer or DPI	Mouthpiece	DPI requires sufficient inspiratory flow (≥30 L/min); teach and assess technique
Acute attack (any age)	Nebuliser	Face mask or mouthpiece	Salbutamol 2.5mg (<5yr) or 5mg (≥5yr); also use if unable to coordinate spacer

ℹ️

Evidence: pMDI + spacer delivers equivalent bronchodilation to nebulisation in mild–moderate acute attacks. Preferred in ED and ward — fewer side-effects (tremor, tachycardia).

✅

pMDI + Spacer Technique (Step-by-Step)

Remove cap from pMDI and spacer mouthpiece. Check spacer for debris.

Shake pMDI vigorously for 5 seconds. Insert into spacer.

Hold spacer horizontal. Child breathes out gently (not forcefully into device).

Place mouthpiece between lips (or face mask over nose and mouth for <2yr). Ensure tight seal.

Press canister once to release one dose into spacer chamber.

Child takes 5 slow, tidal breaths in and out through the mouthpiece without removing it.

Wait 30–60 seconds before next actuation. Maximum 3 actuations together for one dose session.

Replace caps. Rinse mouth (after ICS doses) to reduce oral candidiasis risk.

⚠️

Common Inhaler Errors

Not shaking pMDI before use (dose inconsistency)
Poor face mask/mouthpiece seal (drug lost to air)
Actuating multiple puffs at once into spacer (reduces dose delivered)
Not waiting between puffs
Breathing too fast or forcefully (triggers spacer valve ineffectively)
Exhaling into the spacer before actuation (wets mouthpiece)
Using expired or empty inhaler
Storing inhaler in cold place (reduces pMDI performance)

DPI-Specific Errors (≥5 years)

Insufficient inspiratory effort (especially in acute attacks — DPI contraindicated)
Exhaling into DPI device (wets powder, clogs device)
Not loading dose correctly (Turbuhaler: twist-and-click; Accuhaler: slide lever)

🧹

Spacer Care & Maintenance

Wash spacer monthly with warm water and washing-up liquid (reduces static charge)
Air dry — do NOT towel dry (static charge causes drug to stick to walls)
Do NOT rinse with clean water alone — this increases static
Check for cracks or valve damage at each clinical contact
Replace spacer every 6–12 months (or sooner if damaged)
Label spacer with child's name — spacers are personal items, not shared

🎓

Demonstration Approach

Effective inhaler education follows a demonstrate–observe–correct model:

Nurse demonstrates full technique using placebo device — narrate each step
Patient/parent return-demonstrates — observe without interrupting
Nurse corrects errors specifically and re-demonstrates if needed
Repeat at every contact — technique deteriorates over time
Document technique assessment in nursing notes

✅

Include school nurses, teachers, and child's key contacts. Inhaler technique is a shared responsibility across the child's environment.

🚨

Acute Asthma Severity Assessment — Children (BTS)

Parameter	Mild	Moderate	Severe	Life-Threatening
SpO₂	≥95%	92–95%	<92%	<92% (not responding)
PEFR (% predicted)	>50%	33–50%	<33%	<33% or unmeasurable
Speech	Full sentences	Short sentences	Words only	Cannot speak
Work of Breathing	None / minimal	Mild recession	Marked recession, accessory muscles	Poor respiratory effort / exhaustion
Other Features	—	Tachycardia, tachypnoea	Too breathless to feed/walk	Silent chest, cyanosis, altered consciousness, exhaustion

🔴

Silent chest in a child with asthma = medical emergency. Absent wheeze does not mean improvement — it indicates near-total airway obstruction. Escalate immediately.

🧮

Paediatric Asthma Severity Classifier

Enter Patient Parameters

SpO₂ (%)

PEFR % Predicted (if available)

Age (years)

Weight (kg) — optional for dosing

Ability to Talk

Work of Breathing

Life-Threatening Features Present? (tick all that apply)

Silent chest on auscultation Central cyanosis (blue lips/fingernails) Altered consciousness (confused / drowsy / unresponsive) Exhaustion / poor respiratory effort

💊

Salbutamol Doses — Acute Attack

Mild Attack — pMDI + Spacer

2–4 puffs (100mcg/puff)

Repeat every 20–30 min as needed for first hour

Moderate–Severe — pMDI + Spacer (preferred)

4–10 puffs

One puff at a time, every 20–30 min x3, then reassess

Nebulised Salbutamol (severe / unable to use spacer)

<5 yr: 2.5 mg | ≥5 yr: 5 mg

Every 20–30 min x3, then every 1–4 hr. Driven by O₂ at 6–8 L/min

💉

Additional Medications

Ipratropium (Severe / Life-Threatening)

<12 yr: 0.25 mg | ≥12 yr: 0.5 mg

Nebulised, every 20 min x3 doses, then as required. Add to salbutamol nebule.

Oral Prednisolone (moderate–severe)

1–2 mg/kg/day (max 40 mg)

For 3–5 days. Start early — reduces hospital admission risk.

IV Magnesium Sulphate (life-threatening)

40 mg/kg IV (max 2 g) over 20 minutes

Single dose. For life-threatening asthma not responding to initial bronchodilators and steroids.

🏥

PICU Criteria — When to Escalate

Escalate to PICU if ANY of:

Exhaustion / poor respiratory effort despite treatment
SpO₂ <92% on 40% inspired oxygen
Worsening clinical picture despite 1 hour of maximum treatment
Silent chest + cyanosis
Altered or reduced consciousness
Life-threatening features not improving with magnesium
Need for intubation / ventilation

Consider Heliox

Helium-oxygen mixture (Heliox 80:20 or 70:30) reduces turbulent airflow. Consider in severe wheeze not responding to bronchodilators. Reduces work of breathing while pharmacological treatment takes effect. Not widely available — specialist/PICU setting only.

⚠️

Heliox cannot be used if child requires >40% oxygen — helium concentration too low to be effective.

📋

Personal Asthma Action Plan (PAAP)

Every child with asthma should have a written, colour-coded PAAP completed jointly with the family, reviewed at least annually and after every acute attack.

Green Zone

Doing Well

No symptoms or night waking
PEFR >80% personal best
Using reliever ≤2×/week
Action: Continue preventer as prescribed

Amber Zone

Getting Worse

Increasing symptoms/night waking
PEFR 50–80% personal best
Reliever needed more than usual
Action: Increase reliever frequency; start oral prednisolone if PAAP indicates; contact GP within 24 hr

Red Zone

Medical Emergency

Severe symptoms, PEFR <50%
Not improving with reliever
Blue lips or fingernails
Action: 10 puffs salbutamol; call 999 / go to ED immediately

📈

BTS/SIGN Stepwise Therapy — Children

Step	Treatment	Notes
Step 1	SABA (salbutamol) PRN only	For intermittent/mild symptoms. Frequent SABA use signals inadequate control — step up.
Step 2	Add low-dose ICS (Fluticasone or Beclomethasone) — age-appropriate device	Start ICS when using SABA >3×/week. Fluticasone 50mcg BD or Beclomethasone 100mcg BD.
Step 3	<5yr: Add LTRA (Montelukast) \| ≥5yr: Add LABA (Salmeterol) or LTRA	Montelukast is oral — better adherence in young children. LABA only as add-on to ICS (never alone).
Step 4	Increase ICS dose + LABA. Consider LTRA, Theophylline (older children)	Refer to paediatric respiratory specialist. Confirm diagnosis before escalating.
Step 5	Paediatric respiratory specialist. Consider biologics (severe eosinophilic), oral steroids	Anti-IL5 (mepolizumab) licensed ≥6yr in severe eosinophilic asthma. Multidisciplinary review.

⚠️

Step down every 3 months once good control is achieved for 3 months. Always confirm inhaler technique and adherence before stepping up therapy.

🔍

Adherence Monitoring

Check inhaler technique at every appointment
Examine Turbuhaler dose counter — confirm medication has been taken
Review pharmacy refill records — under-refilling = under-use; over-refilling = poor control
Ask about missed doses non-judgementally: "Most families find it difficult to give it every day — how are you finding it?"
Consider once-daily dosing regimens where available (ciclesonide, mometasone) to improve adherence

Allergen Reduction Advice

Dust mite-proof mattress/pillow covers
No smoking or shisha in the home — ever
Pet removal or exclusion from bedroom (if allergen-sensitised)
Cockroach control (professional pest management in GCC housing)
Good ventilation; address damp/mould promptly

🏫

School Management Plan — GCC Context

A separate school asthma plan should be completed for every school-age child. In GCC, school health nurses are present in most government schools and act as key coordinators.

Provide a copy of PAAP to the school health nurse and class teacher
Keep a spare labelled reliever inhaler + spacer at school in the nurse's office
Teach school nurse correct spacer technique and emergency protocol
Pre-exercise salbutamol: 2 puffs before outdoor PE / school sports
GCC heat context: outdoor PE in extreme summer heat (40–50°C) is a significant asthma trigger — advise early morning activities or indoor alternatives
Sandstorm days: child should not attend outdoor play areas; keep indoors and ensure reliever is accessible
Notify school if child has had a recent attack or step-up in treatment

📚

Asthma Education Principles

Age-Appropriate Approach

Under 5: Education directed entirely at parents/carers. Use simple language, visual aids, and demonstration.
Age 5–6: Begin to include child. Explain "the breathing disease" using simple terms. Show the child their inhaler.
Age 7–12: Child takes increasing role — can be taught to recognise symptoms and activate PAAP. Involve in inhaler technique.
Adolescents: Child should lead their own management. Address self-management, peer pressure, exercise, and disclosure at school.

Core Teaching Topics

What is asthma — airways, inflammation, reversibility
Difference between reliever (blue) and preventer (usually brown/orange/purple)
Correct inhaler technique (return demonstration each visit)
How to use the PAAP — green/amber/red zones
Recognising worsening and when to seek emergency help
Trigger identification and avoidance strategies

🚨

Red Flag Symptoms — Seek Emergency Care

🔴

Call 999 / Go to ED immediately if:

Salbutamol has been given and symptoms are not improving after 10 puffs
Child has blue lips or fingernails (cyanosis)
Child is too breathless to speak or feed
Child appears exhausted — drowsy, limp, not reacting normally
Breathing is very fast and laboured with neck/chest muscles working hard
Child is worse than their worst ever attack

⚠️

While waiting for emergency services: give up to 10 puffs salbutamol via spacer (1 puff, 5 breaths × 10). Sit child upright. Stay calm.

💪

Trigger Avoidance

Highest Impact Interventions

Smoking / shisha cessation: Most impactful single intervention. Include passive exposure — no smoking in home or car. Refer parents to smoking cessation service.
URTI prevention: Hand hygiene education, avoid crowded indoor settings during illness season, keep child home when acutely unwell.

Exercise-Induced Asthma

Pre-treatment with 2 puffs salbutamol 15 minutes before exercise effectively prevents exercise-induced bronchospasm. This does not mean avoiding sport — children should be encouraged to exercise and participate fully.

Vaccinations

Annual influenza vaccine — recommended for all children with asthma. Reduces URTI-triggered attacks significantly.
COVID-19 vaccine — follow national schedule; reduces infective trigger risk.

☪️

Ramadan & Asthma — GCC Cultural Context

Many Muslim families in the GCC worry that using an inhaler during Ramadan fasting hours will break the fast. This is a significant barrier to adherence and leads to poorly controlled asthma during Ramadan.

✅

Islamic scholarly consensus (fatwa): Using an inhaler during Ramadan does NOT break the fast. The medication enters the lungs, not the stomach, and there is no nutritional intake.

Advise families to clarify this with their own religious scholar if uncertain — healthcare professionals should not provide religious rulings, but can share that this is the widely accepted medical-religious position.

Practical Nursing Advice for Ramadan

Review medication regimen before Ramadan — can preventer ICS be adjusted to once-daily dosing?
Ensure child/family understands reliever use is permitted and essential during attacks
Discuss timing of medications — can once-daily preventer be taken at Iftar or Suhoor?
Consider nebulisers — these are more clearly accepted as not breaking fast (no aerosol reaches stomach)
Never advise a child to withhold their reliever inhaler during an acute attack due to fasting
Document discussion in notes and provide written information in Arabic where possible

⭐

GCC Exam Boards: DHA (Dubai), DOH (Abu Dhabi), SCFHS (Saudi), QCHP (Qatar). Paediatric asthma is a high-yield topic. Focus on severity classification, correct dosing, inhaler device selection, and PAAP principles.

📊

BTS Severity Classification — Exam Table

Feature	Mild	Moderate	Severe	Life-Threatening
SpO₂	≥95%	92–94%	<92%	<92% (not improving)
PEFR	>50%	33–50%	<33%	<33% or unmeasurable
Speech	Full sentences	Short sentences	Words only	Cannot speak
Salbutamol dose (pMDI)	2–4 puffs	4–10 puffs	4–10 puffs + nebulise	Continuous nebulisation
Ipratropium	No	No	Yes	Yes
Prednisolone	Consider if no improvement	Yes — start early	Yes — start immediately	IV hydrocortisone
Magnesium IV	No	No	Consider	Yes — 40mg/kg (max 2g)

📱

Inhaler Device by Age — Exam Table

Age	Preferred Device	Interface	DPI Suitable?
<2 yr	pMDI + spacer	Face mask	No
2–4 yr	pMDI + spacer	Mouthpiece or mask	No
≥5 yr	pMDI + spacer or DPI	Mouthpiece	Yes (if technique adequate)
Acute (any age)	Nebuliser	Mask or mouthpiece	No — DPI contraindicated

❓

High-Yield Exam Questions

1. A 4-year-old child presents with wheeze, SpO₂ 90%, and can only speak in words. What severity of acute asthma is this and what is the immediate treatment priority?

Severe asthma. SpO₂ <92% and speech limited to words both indicate severe. Immediate: oxygen to maintain SpO₂ 94–98%, salbutamol 2.5mg nebulised (or 4–10 puffs via spacer), add ipratropium 0.25mg nebulised, oral prednisolone 1–2mg/kg. Reassess in 15 minutes. If SpO₂ <92% despite 40% O₂ — consider PICU referral.

2. Which inhaler device is most appropriate for a 2-year-old child with asthma requiring regular ICS therapy?

pMDI + spacer + face mask. Under 2 years, children cannot seal lips around a mouthpiece. A face mask with a valved spacer (e.g., Aerochamber) allows tidal breathing to deliver drug to the lungs. DPIs are not appropriate under 5 years.

3. A school-age child with asthma develops symptoms only during physical education class. What is the recommended management?

Exercise-induced asthma — pre-treatment. 2 puffs salbutamol 15 minutes before exercise. This does not mean avoiding sport. Review asthma control — if frequent exercise-triggered symptoms, step up preventer therapy (regular ICS). Ensure spare inhaler is kept at school. In GCC: advise early morning PE times to avoid extreme midday heat.

4. What is the correct dose of IV magnesium sulphate in a 25kg child with life-threatening asthma?

40mg/kg × 25kg = 1,000mg (1g) IV over 20 minutes. Maximum dose is 2g regardless of weight. Magnesium is a smooth muscle relaxant with bronchodilatory effect. Used as a single dose in life-threatening asthma not responding to initial bronchodilators and steroids.

5. A Muslim family tells you their child (9 years) refuses to use the preventer inhaler during Ramadan fasting hours. What is the appropriate nursing response?

Provide evidence-based reassurance and practical support. Explain that the widely accepted Islamic scholarly position is that inhalers do not break the fast (medication goes to the lungs, not the stomach). Do not provide a religious ruling — advise the family to speak with their own scholar if they wish. Practically: consider once-daily ICS dosing at Iftar. Document the discussion. Never advise withholding medication during an acute attack.

6. What does a positive Asthma Predictive Index (API) indicate, and what are the major criteria?

Positive API predicts persistent asthma at school age in children <3 years with recurrent wheeze. Major criteria: parental asthma, atopic dermatitis (eczema), sensitisation to aeroallergen. Minor criteria: allergic rhinitis, wheeze not triggered by colds, eosinophilia ≥4%. Positive = 1 major + 2 minor criteria.

7. What is the key difference between spacer washing technique and why is towel drying dangerous?

Wash with washing-up liquid (detergent reduces static charge), then air dry only. Towel drying creates static electricity on the spacer walls. Static causes drug particles to adhere to the spacer interior rather than being inhaled — significantly reducing drug delivery to the lungs. Rinsing with plain water (without detergent) also increases static.

8. In the BTS stepwise approach, which add-on medication is preferred at Step 3 for a 3-year-old child with asthma not controlled on low-dose ICS alone?

Montelukast (LTRA — leukotriene receptor antagonist). In children under 5 years, montelukast (oral) is preferred over LABA at Step 3. LABAs (salmeterol) are an option at Step 3 for children ≥5 years but must only be used in combination with ICS, never alone.

🏥

PICU Referral Criteria — Quick Reference

Refer to PICU if ANY of the following:

SpO₂ <92% on ≥40% inspired oxygen despite treatment
Worsening clinical state despite 1 hour maximal therapy
Silent chest + cyanosis
Exhaustion / poor respiratory effort
Altered consciousness (confusion, drowsiness, unresponsive)
Life-threatening features not responding to IV magnesium
Clinical decision to intubate and ventilate
Previous PICU admission for asthma — lower threshold